Reversible sulcal FLAIR hyperintensity on MRI in a migraine patient with aura.

Eduardo Portela de Oliveira, Vered Tsehmaister-Abitbul, Mario Kontolemos, Rafael Glikstein, Carlos Torres

Abstract readCase Reports

In one paragraph

Article in Radiology case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eduardo Portela de OliveiraUniversity of Ottawa, Department of Radiology, The Ottawa Hospital, Department of Medical Imaging, Box 232, General Campus Room 1466e, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6.

Vered Tsehmaister-AbitbulUniversity of Ottawa, Department of Radiology, The Ottawa Hospital, Department of Medical Imaging, Box 232, General Campus Room 1466e, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6.

Mario KontolemosUniversity of Ottawa, Department of Radiology, The Ottawa Hospital, Department of Medical Imaging, Box 232, General Campus Room 1466e, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6.

Rafael GliksteinUniversity of Ottawa, Department of Radiology, The Ottawa Hospital, Department of Medical Imaging, Box 232, General Campus Room 1466e, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6.

Carlos TorresUniversity of Ottawa, Department of Radiology, The Ottawa Hospital, Department of Medical Imaging, Box 232, General Campus Room 1466e, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reversible sulcal fluid-attenuated inversion recovery (FLAIR) hyperintensity is a rare imaging finding that could be seen on magnetic resonance imaging (MRI), in patients with migraine with aura. Herein, we present a patient who was admitted to the emergency department with severe headaches, numbness on the right side of the body, and visual changes. MRI showed sulcal FLAIR hyperintensity in the occipital lobes, with no other abnormality. The patient was diagnosed with migraine with aura by neurology and the follow up MRI showed resolution of the finding, supporting the diagnosis. Sulcal hyperintensity on FLAIR is a nonspecific imaging finding that can occur with or without cerebral spinal fluid (CSF) abnormality. Although, clinical correlation and CSF analysis may be required, radiologists may often be able to suggest the cause of abnormal CSF signal depending on the distribution of sulcal FLAIR hyperintensity, and the presence of additional imaging findings.

Indexed as

FLAIR hyperintensityMagnetic resonance imagingMigraine with auraReversibleSulcal hyperintensity

Identifiers

PMID31890062

DOI10.1016/j.radcr.2019.10.029

PMCPMC6923487

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.